Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 25;115(9):1131-1139.
doi: 10.1038/bjc.2016.285. Epub 2016 Sep 15.

Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers

Jyoti Malhotra  1   2 , Tim Waterboer  3 , Michael Pawlita  3 , Angelika Michel  3 , Qiuyin Cai  4 , Wei Zheng  4 , Yu-Tang Gao  5 , Qing Lan  6 , Nathaniel Rothman  6 , Hilde Langseth  7 , Tom K Grimsrud  7 , Jian-Min Yuan  8 , Woon-Puay Koh  9 , Renwei Wang  8 , Alan A Arslan  10 , Anne Zeleniuch-Jacquotte  10 , Paolo Boffetta  1
Affiliations

Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers

Jyoti Malhotra et al. Br J Cancer. .

Abstract

Background: Lung cancer in never smokers is a significant contributor of cancer mortality worldwide. In this analysis, we explored the role of nine human polyomaviruses, including JC virus (JCV), BK virus (BKV) and Merkel cell virus (MCV), in lung cancer development in never smokers as there are data to support that polyomaviruses are potentially carcinogenic in the human lung.

Methods: We used multiplex serology to detect serum antibodies to polyomaviruses in a nested case-control design combining lung cancer cases and controls from four cohort studies - NYU Women's Health Study (NYU-WHS), Janus Serum Bank, Shanghai Women's Health Study and Singapore Chinese Health Study (SCHS).

Results: The final analyses included 511 cases and 508 controls. Seroprevalence for each polyomavirus showed significant heterogeneity by study, but overall there were no statistically significant differences between cases and controls. In total, 69.1% of the cases and 68.7% of the controls were seropositive for JCV VP1 antibody. Seropositivity for BKV was higher at 89.0% in cases and 89.8% in controls and lower for MCV at 59.3% in cases and 61.6% in controls. Similar results were obtained after adding an additional retrospective case-control study (Xuanwei study) to the analysis.

Conclusions: Our results do not support the hypothesis that seropositivity for polyomaviruses is associated with increased lung cancer risk in never smokers. Future research to evaluate relationship between polyomavirus infection and lung carcinogenesis should focus more on evaluating the presence of virus or viral nucleic acids (DNA or RNA) in lung tumour samples.

PubMed Disclaimer

References

    1. Abdel-Aziz HO, Murai Y, Hong M, Kutsuna T, Takahashi H, Nomoto K, Murata S, Tsuneyama K, Takano Y (2007) Detection of the JC virus genome in lung cancers: possible role of the T-antigen in lung oncogenesis. Appl Immunohistochem Mol Morphol 15: 394–400. - PubMed
    1. Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MA, Dalianis T, Ramqvist T, Andersson B (2007) Identification of a third human polyomavirus. J Virol 81: 4130–4136. - PMC - PubMed
    1. Amos CI, Pinney SM, Li Y, Kupert E, Lee J, De Andrade MA, Yang P, Schwartz AG, Fain PR, Gazdar A, Minna J, Wiest JS, Zeng D, Rothschild H, Mandal D, You M, Coons T, Gaba C, Bailey-Wilson JE, Anderson MW (2010) A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. Cancer Res 70: 2359–2367. - PMC - PubMed
    1. Anantharaman D, Gheit T, Waterboer T, Halec G, Carreira C, Abedi-Ardekani B, Mckay-Chopin S, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Mates D, Janout V, Foretova L, Bencko V, Rudnai P, Fabianova E, Tjonneland A, Travis RC, Boeing H, Quiros JR, Johansson M, Krogh V, Bueno-De-Mesquita HB, Kotanidou A, Clavel-Chapelon F, Weiderpass E, Johansson M, Pawlita M, Scelo G, Tommasino M, Brennan P (2014) No causal association identified for human papillomavirus infections in lung cancer. Cancer Res 74: 3525–3534. - PubMed
    1. Antonsson A, Green AC, Mallitt KA, O'rourke PK, Pandeya N, Pawlita M, Waterboer T, Neale RE (2010. a) Prevalence and stability of antibodies to 37 human papillomavirus types – a population-based longitudinal study. Virology 407: 26–32. - PubMed